Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates - subtype selective, high affinity α7 nicotinic acetylcholine receptor agonists

被引：11

作者：

O'Donnell, Christopher J. ^{[1
]}

Peng, Langu ^{[1
]}

O'Neill, Brian T. ^{[1
]}

Arnold, Eric P. ^{[1
]}

Mather, Robert J. ^{[1
]}

Sands, Steven B. ^{[1
]}

Shrikhande, Alka ^{[1
]}

Lebel, Lorraine A. ^{[1
]}

Spracklin, Douglas K. ^{[1
]}

Nedza, Frank M. ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, Neurosci Med Chem, Groton, CT 06340 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 16期

关键词：

Alpha; 7; Nicotinic acetylcholine receptor; nAChR; SAR; 1,4-Diazabicyclo[3.2.2]nonane phenyl carbamate; Agonist; RAT-BRAIN; IN-VITRO; BINDING; SCHIZOPHRENIA; SITES; ANALOG;

D O I：

10.1016/j.bmcl.2009.06.059

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The synthesis and SAR studies about the bicyclic amine, carbamate linker and aromatic ring of a 1,4-diazabicyclo[3.2.2]nonane phenyl carbamate series of alpha 7 nAChR agonists is described. The development of the medicinal chemistry strategy and SAR which led to the identification of 5 and 7aa as subtype selective, high affinity alpha 7 agonists as excellent leads for further evaluation is discussed, along with key physicochemical and pharmacokinetic data highlighting their lead potential. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：4747 / 4751

页数：5

共 30 条

[11]

Lightfoot AP, 2008, PROGR MED CHEM, V46, P131, DOI 10.1016/S0079-6468(07)00003-3

[12]

LIPPIELLO PM, 1986, MOL PHARMACOL, V29, P448

[13] A review of the effects of nicotine on schizophrenia and antipsychotic medications [J].

Lyon, ER .

PSYCHIATRIC SERVICES, 1999, 50 (10) :1346-1350

[14]

MACOR J, 1997, Patent No. 9730998

[15] SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF 7-DIAZABICYCLOALKYLQUINOLONES, INCLUDING DANOFLOXACIN, A NEW QUINOLONE ANTIBACTERIAL AGENT FOR VETERINARY-MEDICINE [J].

MCGUIRK, PR ;

JEFSON, MR ;

MANN, DD ;

ELLIOTT, NC ;

CHANG, P ;

CISEK, EP ;

CORNELL, CP ;

GOOTZ, TD ;

HASKELL, SL ;

HINDAHL, MS ;

LAFLEUR, LJ ;

ROSENFELD, MJ ;

SHRYOCK, TR ;

SILVIA, AM ;

WEBER, FH .

JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (04) :611-620

[16] SYNTHESIS AND BIOLOGICAL EVALUATION OF CONFORMATIONALLY CONSTRAINED BICYCLIC AND TRICYCLIC BALANOL ANALOGS AS INHIBITORS OF PROTEIN-KINASE-C [J].

MENDOZA, JS ;

JAGDMANN, GE ;

GOSNELL, PA .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (19) :2211-2216

[17]

MIKHLINA EE, 1963, ZH OBSHCH KHIM+, V33, P2167

[18] (-)-spiro[1-azabicyclo[2.2.2]octane-3,5′-oxazolidin-2′-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the α7 nicotinic acetylcholine receptor [J].

Mullen, G ;

Napier, J ;

Balestra, M ;

DeCory, T ;

Hale, G ;

Macor, J ;

Mack, R ;

Loch, J ;

Wu, E ;

Kover, A ;

Verhoest, P ;

Sampognaro, A ;

Phillips, E ;

Zhu, YY ;

Murray, R ;

Griffith, R ;

Blosser, J ;

Gurley, D ;

Machulskis, A ;

Zongrone, J ;

Rosen, A ;

Gordon, J .

JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (22) :4045-4050

[19]

ODONNELL CJ, 2002, Patent No. 02177591

[20] Treating schizophrenia symptoms with an α7 nicotinic agonist, from mice to men [J].

Olincy, Ann ;

Stevens, Karen E. .

BIOCHEMICAL PHARMACOLOGY, 2007, 74 (08) :1192-1201

← 1 2 3 →